Analyst Downgrades: SanDisk Corporation, Abbott Laboratories, and ChannelAdvisor Corporation

Analysts downwardly revised their ratings on SanDisk Corporation (SNDK), Abbott Laboratories (ABT), and ChannelAdvisor Corp (ECOM)

by Alex Eppstein

Published on Jan 13, 2015 at 9:21 AM
Updated on Apr 20, 2015 at 5:32 PM

Analysts are weighing in today on flash memory expert SanDisk Corporation (NASDAQ:SNDK), pharmaceutical firm Abbott Laboratories (NYSE:ABT), and enterprise software provider ChannelAdvisor Corp (NYSE:ECOM). Here's a quick roundup of today's bearish brokerage notes on SNDK, ABT, and ECOM.

  • After estimating weaker-than-expected fourth-quarter sales yesterday and consequently losing nearly 14% to settle at $83.57, SNDK received a rush of negative analyst attention. No fewer than nine brokerage firms reduced their price targets on the stock, while Needham downgraded SanDisk Corporation to "hold" from "buy." Despite Monday's losses, shares of the chipmaker remain more than 17% higher on a year-over-year basis. As such, 19 out of 22 covering analysts rate SNDK a "buy" or better, compared to three "holds" and not a single "sell." Also, the equity's consensus 12-month price target of $107.89 represents a 29.1% premium to current trading levels. Additional downgrades and/or price-target cuts could drag the security even lower. Looking ahead, SNDK will report fourth-quarter earnings next Wednesday night.

  • Jefferies downgraded ABT to "hold" from "buy," and reduced its price target by $2 to $50. This is somewhat surprising, given the shares' 16.5% year-over-year advance to perch at $45.34 -- just a chip-shot away from their record high of $46.50, touched in late December. While Jefferies may be skeptical of Abbott Laboratories, this is hardly true of options traders. During the last two weeks at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the security has racked up a call/put volume ratio of 12.78 -- in the 86th percentile of its annual range.

  • Finally, ECOM reduced its fourth-quarter revenue guidance last night, and the brokerage bunch has responded in force. Specifically, Baird, Stifel, and Raymond James all downgraded the stock to the equivalent of a "hold" from a "buy." Additionally, Baird slashed its price target on ChannelAdvisor Corp to $18 from $32, and Needham cut its target to $22 from $30, while reiterating a "buy" opinion. Accordingly, ECOM shares are pointed roughly 47% lower ahead of the bell, which would add to their year-over-year deficit of 54.2% -- as of last night's close at $21.15. Short sellers have reacted strongly to this longer-term swoon, as short interest rose nearly 15% during the most recent reporting period. Currently, 18.5% of the equity's float is sold short, which would take 12 days to cover, at typical daily trading volumes.

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Huge New Legal Marijuana Market Has Shortage Crisis
250 million Europeans have access to medical marijuana. There's already a shortage....
Tiffany Stock Drops as Takeover Talks Dissipate
LVMH was to acquire Tiffany & Co in a billion-dollar deal
Coty Stock Glows Up with Possible Kardashian Cosmetics Line
The trendy cosmetics company is in talks with reality TV star Kim Kardashian West over a line of beauty products
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.